Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tdap Vaccine Immunogenicity in Post-Partum Women
NCT01711645Phase 4Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2012
- Primary completion
- Aug 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of acellular pertussis vaccine in diphtheria, Tetanus, pertussis, sponsored by National Institute of Allergy and Infectious Diseases. Started Oct 2012; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on NCT01711645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01711645.